| Von O Hill, MPT | |
|
77 S 400 W, Spanish Fork, UT 84660-2053 | |
| (801) 798-1626 | |
| (801) 798-1236 |
| Full Name | Von O Hill |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 30 Years |
| Location | 77 S 400 W, Spanish Fork, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669472684 | NPI | - | NPPES |
| D0863/870578539003 | Medicaid | UT | |
| 695780 | Other | UT | DMBA PROVIDER ID# |
| 870578539HI1 | Other | UT | EDUCATORS MUTUAL ID# |
| QM0000076331 | Other | UT | ALTIUS PROVIDER ID# |
| 35169 | Other | UT | PEHP PROVIDER ID |
| 107009208102 | Other | UT | IHC HEALTH PLANS ID# |
| 64-00214 | Other | UNITED HEALTHCARE ID# |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 2757752401 (Utah) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Professional Therapy And Rehabilitation Llc | 3476441767 | 4 |
News Archive
On December 1, 2009 at the annual Prostate Cancer Foundation Annual Dinner, the organization acknowledged its sponsors and provided insight of the year's events and milestones. Gamma Labs, a leading nutritional supplement company, was recognized as one of the organization's sponsors. Gamma Labs is pleased to announce today plans to continue support of this organization. Gamma Labs serves as a sponsor for the Charles Evans PCF Pro/Am Tour, an annual event that benefits the Prostate Cancer Foundation.
EpiCept Corporation today announced operating and financial results for the fourth quarter and full year ended December 31, 2010, and provided an update on its key business initiatives.
Teva Pharmaceutical Industries Ltd. today announced that data from four late-stage studies examining QNASL (beclomethasone dipropionate [BDP]) HFA, a nasal aerosol corticosteroid in development for the treatment of seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR) symptoms, will be presented at the 2011 Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Boston, Mass., November 3-8, 2011.
Progenra, Inc., announced today their receipt of an Official Notice of Allowance, dated June 15, 2010, of U.S. Patent Application No. 11/156,707, "Diagnostic and Screening Methods and Kits Associated with Proteolytic Activity." IP protection of this technology was also recently granted by the European Union. This technology will enable faster drug discovery by improving the ability to identify more selective drugs that modulate the handling of proteins associated with various disease states.
› Verified 4 days ago
| Provider Name | Professional Therapy And Rehabilitation Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1629259189 PECOS PAC ID: 3476441767 Enrollment ID: O20040308001466 |
News Archive
On December 1, 2009 at the annual Prostate Cancer Foundation Annual Dinner, the organization acknowledged its sponsors and provided insight of the year's events and milestones. Gamma Labs, a leading nutritional supplement company, was recognized as one of the organization's sponsors. Gamma Labs is pleased to announce today plans to continue support of this organization. Gamma Labs serves as a sponsor for the Charles Evans PCF Pro/Am Tour, an annual event that benefits the Prostate Cancer Foundation.
EpiCept Corporation today announced operating and financial results for the fourth quarter and full year ended December 31, 2010, and provided an update on its key business initiatives.
Teva Pharmaceutical Industries Ltd. today announced that data from four late-stage studies examining QNASL (beclomethasone dipropionate [BDP]) HFA, a nasal aerosol corticosteroid in development for the treatment of seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR) symptoms, will be presented at the 2011 Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Boston, Mass., November 3-8, 2011.
Progenra, Inc., announced today their receipt of an Official Notice of Allowance, dated June 15, 2010, of U.S. Patent Application No. 11/156,707, "Diagnostic and Screening Methods and Kits Associated with Proteolytic Activity." IP protection of this technology was also recently granted by the European Union. This technology will enable faster drug discovery by improving the ability to identify more selective drugs that modulate the handling of proteins associated with various disease states.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Von O Hill, MPT 77 S 400 W, Spanish Fork, UT 84660-2053 Ph: (801) 798-1626 | Von O Hill, MPT 77 S 400 W, Spanish Fork, UT 84660-2053 Ph: (801) 798-1626 |
News Archive
On December 1, 2009 at the annual Prostate Cancer Foundation Annual Dinner, the organization acknowledged its sponsors and provided insight of the year's events and milestones. Gamma Labs, a leading nutritional supplement company, was recognized as one of the organization's sponsors. Gamma Labs is pleased to announce today plans to continue support of this organization. Gamma Labs serves as a sponsor for the Charles Evans PCF Pro/Am Tour, an annual event that benefits the Prostate Cancer Foundation.
EpiCept Corporation today announced operating and financial results for the fourth quarter and full year ended December 31, 2010, and provided an update on its key business initiatives.
Teva Pharmaceutical Industries Ltd. today announced that data from four late-stage studies examining QNASL (beclomethasone dipropionate [BDP]) HFA, a nasal aerosol corticosteroid in development for the treatment of seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR) symptoms, will be presented at the 2011 Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Boston, Mass., November 3-8, 2011.
Progenra, Inc., announced today their receipt of an Official Notice of Allowance, dated June 15, 2010, of U.S. Patent Application No. 11/156,707, "Diagnostic and Screening Methods and Kits Associated with Proteolytic Activity." IP protection of this technology was also recently granted by the European Union. This technology will enable faster drug discovery by improving the ability to identify more selective drugs that modulate the handling of proteins associated with various disease states.
› Verified 4 days ago
Jason G Williams, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 77 S 400 W, Spanish Fork, UT 84660 Phone: 801-798-1626 Fax: 801-798-1236 | |
Mrs. Allison May Jenson, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 132 W Volunteer Dr B, Spanish Fork, UT 84660 Phone: 801-436-3110 | |
Mark Jones, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 350 S Main St, Spanish Fork, UT 84660 Phone: 801-354-7416 | |
Chantel Mitton, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 820 Expressway Ln, Spanish Fork, UT 84660 Phone: 801-794-0333 | |
Amelia Fullmer, Physical Therapist Medicare: Medicare Enrolled Practice Location: 765 E Market Place Dr, Spanish Fork, UT 84660 Phone: 385-344-5430 | |
David Adam Tervort, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 820 Expressway Ln, Spanish Fork, UT 84660 Phone: 801-357-0333 Fax: 801-794-9553 | |
Dr. Robert Mason Snow, DPT, OCS, ATC CSCS Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 205 N Main St, Spanish Fork, UT 84660 Phone: 801-436-3110 Fax: 801-436-3110 |